Co-expression of epidermal growth factor receptor and transforming growth factor-α is independent of ras mutations in lung adenocarcinoma

Lung Cancer

Volumn 29, Issue 2, 2000, Pages 151-157

  Hsieh, Eugene T K ^a   Shepherd, Frances A ^a   Tsao, Ming Sound ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Autocrine growth factor; Immunohistochemistry; Signal transduction; Tyrosine kinase receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0033841640     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00116-1     Document Type: Article

References (28)

1. Earp H.S., Dawson T.L., Li X. et al. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat. 35:1995;115-132.
2. Beerli R.R., Hynes N.E. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 271:1996;6071-6076.
3. Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell. 80:1995;213-223.
4. RieseII D.J., Kim E.D., Elenius K. et al. The epidermal growth factor receptor couples transforming growth factor-α, heparin-binding epidermal growth factgor-like factor and amphiregulin to Neu, ErbB-3 and ErbB-4. J. Biol. Chem. 271:1996;20047-20052.
5. Boguski M.S., McCormick F. Proteins regulating ras and its relatives. Nature. 366:1993;643-654.
6. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
7. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. Increasing complexity of ras signaling. Oncogene. 17:1998;1395-1413.
8. Bos J.L. ras Oncogenes in human cancer: a review. Cancer Res. 49:1989;4682-4689.
9. Rodenhuis S., Slebos R.J. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. 52:1992;2665s-2669s.
10. Medema R.H., Bos J.L. The role of p21ras in receptor tyrosine kinase signaling. Crit. Rev. Oncogen. 4:1993;615-661.
11. Cerny T, Barnes DM, Hasleton P et al. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br. J. Cancer. 54:1986;265-269.
12. Berger M.S., Gullick W.J., Greenfield C. et al. Epidermal growth factor receptors in lung tumours. J. Pathol. 152:1987;297-307.
13. Veale D., Ashcroft T., Marsh C., Gibson G.J., Harris A.L. Epidermal growth factor receptors in non small cell lung cancer. Br. J. Cancer. 55:1987;513-516.
14. Haeder M., Rotsch M., Bepler G. et al. Epidermal growth factor receptor expression in human lung cancer cell lines. Cancer Res. 48:1988;1132-1136.
15. Dazzi H., Hasleton P.S., Thatcher N. et al. Expression of epidermal growth factor receptor (EGF-R) in non small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumor size, node status and survival. Br. J. Cancer. 59:1989;746-749.
16. Ozanne B., Richards C.S., Hendler F., Burns D., Gusterson B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J. Pathol. 149:1986;9-14.
17. Veale D., Kerr N., Gibson G.J., Harris A.L. Characterization of epidermal growth factor receptor in primary human non small cell lung cancer. Cancer Res. 49:1989;1313-1317.
18. Liu C., Tsao M.S. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non small-cell lung carcinomas. Am. J. Pathol. 142:1993;1155-1162.
19. Rusch V., Klimstra D., Venkatraman E. et al. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non small cell lung cancer but does not predict tumor progression. Clin. Cancer Res. 3:1997;515-522.
20. Yamaguchi K., Imanishi K., Maruno K. et al. Lung cancer and autocrine growth factors. Chest. 96:1989;29s-33s.
21. Tsao M.-S., Zhu H., Viallet J. Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells. Exp. Cell. Res. 223:1996;268-273.
22. Tsao M.S., Liu N., Nicklee T., Shepherd F., Viallet J. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non small cell lung carcinoma. Clin. Cancer Res. 3:1997;1807-1814.
23. Histological typing of lung tumours. Am J. Clin. Pathol. 77:1982;123-136.
24. Fleming I.D. Cancer Staging Manual. 5th editionnual:1997;127-137 Lippincott-Raven, Philadelphia.
25. Montgomery R.B., Moscatello D.K., Wong A.J., Cooper J.A., Stahl W.L. Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor. J. Biol. Chem. 270:1995;30562-30566.
26. Moscatello D.K., Holgado-Madruga M., Godwin A.K. et al. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res. 55:1995;5536-5539.
27. Garcia de Palazzp I.E., Adams G.P., Sundareshan P. et al. Expression of mutated epidermal growth factor receptor by non small cell lung carcinomas. Cancer Res. 53:1993;3217-3220.
28. Fan Z., Mendelsohn J. Therapeutic application of anti-growth factor receptor antibodies. Curr. Opin. Oncol. 10:1998;67-73.